These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28812272)

  • 1. Oxytocin and Borderline Personality Disorder.
    Bertsch K; Herpertz SC
    Curr Top Behav Neurosci; 2018; 35():499-514. PubMed ID: 28812272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of oxytocin in borderline personality disorder.
    Brüne M
    Br J Clin Psychol; 2016 Sep; 55(3):287-304. PubMed ID: 26616386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.
    Bertsch K; Gamer M; Schmidt B; Schmidinger I; Walther S; Kästel T; Schnell K; Büchel C; Domes G; Herpertz SC
    Am J Psychiatry; 2013 Oct; 170(10):1169-77. PubMed ID: 23982273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions.
    Amad A; Thomas P; Perez-Rodriguez MM
    Curr Pharm Des; 2015; 21(23):3311-6. PubMed ID: 26088114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin influences avoidant reactions to social threat in adults with borderline personality disorder.
    Brüne M; Ebert A; Kolb M; Tas C; Edel MA; Roser P
    Hum Psychopharmacol; 2013 Nov; 28(6):552-61. PubMed ID: 23950057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Perspective on the Pathophysiology of Borderline Personality Disorder: A Model of the Role of Oxytocin.
    Herpertz SC; Bertsch K
    Am J Psychiatry; 2015 Sep; 172(9):840-51. PubMed ID: 26324303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of oxytocin on social cognition in borderline personality disorder.
    Servan A; Brunelin J; Poulet E
    Encephale; 2018 Feb; 44(1):46-51. PubMed ID: 29273344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of oxytocin on (para-)limbic reactivity to emotional and neutral scenes in females with and without borderline personality disorder.
    Lischke A; Herpertz SC; Berger C; Domes G; Gamer M
    Soc Cogn Affect Neurosci; 2017 Nov; 12(11):1783-1792. PubMed ID: 29036358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intranasal oxytocin administration on empathy and approach motivation in women with borderline personality disorder: a randomized controlled trial.
    Domes G; Ower N; von Dawans B; Spengler FB; Dziobek I; Bohus M; Matthies S; Philipsen A; Heinrichs M
    Transl Psychiatry; 2019 Dec; 9(1):328. PubMed ID: 31801937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased oxytocin plasma levels and oxytocin receptor expression in borderline personality disorder.
    Carrasco JL; Buenache E; MacDowell KS; De la Vega I; López-Villatoro JM; Moreno B; Díaz-Marsá M; Leza JC
    Acta Psychiatr Scand; 2020 Oct; 142(4):319-325. PubMed ID: 32740913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma.
    Ebert A; Kolb M; Heller J; Edel MA; Roser P; Brüne M
    Soc Neurosci; 2013; 8(4):305-13. PubMed ID: 23802121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart and brain: Cortical representation of cardiac signals is disturbed in borderline personality disorder, but unaffected by oxytocin administration.
    Schmitz M; Müller LE; Schulz A; Kleindienst N; Herpertz SC; Bertsch K
    J Affect Disord; 2020 Mar; 264():24-28. PubMed ID: 31846808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring nonverbal synchrony in borderline personality disorder: A double-blind placebo-controlled study using oxytocin.
    Ramseyer F; Ebert A; Roser P; Edel MA; Tschacher W; Brüne M
    Br J Clin Psychol; 2020 Jun; 59(2):186-207. PubMed ID: 31774581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neurobiology of Borderline Personality Disorder.
    Perez-Rodriguez MM; Bulbena-Cabré A; Bassir Nia A; Zipursky G; Goodman M; New AS
    Psychiatr Clin North Am; 2018 Dec; 41(4):633-650. PubMed ID: 30447729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and Neurobiological Correlates of Disturbed Emotion Processing in Borderline Personality Disorder.
    Bertsch K; Hillmann K; Herpertz SC
    Psychopathology; 2018; 51(2):76-82. PubMed ID: 29539627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse childhood experiences mediate the negative association between borderline personality disorder symptoms and plasma oxytocin.
    Mielke EL; Koenig J; Herpertz SC; Steinmann S; Neukel C; Kilavuz P; van der Venne P; Bertsch K; Kaess M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110749. PubMed ID: 36924878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with co-occurring borderline personality disorder among inner-city substance users: the roles of childhood maltreatment, negative affect intensity/reactivity, and emotion dysregulation.
    Gratz KL; Tull MT; Baruch DE; Bornovalova MA; Lejuez CW
    Compr Psychiatry; 2008; 49(6):603-15. PubMed ID: 18970909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Journal Watch review of oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder.
    Jain S
    J Am Psychoanal Assoc; 2014 Aug; 62(4):710-3. PubMed ID: 25135213
    [No Abstract]   [Full Text] [Related]  

  • 19. Intranasal oxytocin as an adjunct treatment among patients with severe major depression with and without comorbid borderline personality disorder.
    Maoz H; Grossman-Giron A; Sedoff O; Nitzan U; Kashua H; Yarmishin M; Arad O; Tzur Bitan D
    J Affect Disord; 2024 Feb; 347():39-44. PubMed ID: 37992767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonverbal communication of patients with borderline personality disorder during clinical interviews: a double-blind placebo-controlled study using intranasal oxytocin.
    Brüne M; Kolb M; Ebert A; Roser P; Edel MA
    J Nerv Ment Dis; 2015 Feb; 203(2):107-11. PubMed ID: 25594788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.